PCRX — Pacira Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapContrarian

Annual balance sheet for Pacira Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	292	522	656	289	279
Net Total Accounts Receivable
Net Total Receivables	47.5	53	96.3	98.4	106
Total Inventory
Prepaid Expenses
Total Current Assets	409	652	866	498	510
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	143	211	265	254	235
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	831	1,275	2,075	1,681	1,574
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	108	253	521	148	97.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	476	655	1,345	906	704
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	355	620	730	775	870
Total Liabilities & Shareholders' Equity	831	1,275	2,075	1,681	1,574
Total Common Shares Outstanding